N-3 Polyunsaturated Fatty Acids Enriched Chicken Meet and Cardiovascular Function

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-09-01

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evidence from multiple experimental, epidemiological, and clinical studies indicate that n-3 polyunsaturated fatty acids (n-3 PUFAs) may exert their cardiovascular (CV) protective effect, at least in part, by improving vascular endothelium-dependent function. Previously, the investigators demonstrated the significant beneficiary effect of consumption of n-3 PUFA-enriched hen eggs on microvascular endothelium-dependent reactivity, even in young healthy individuals.

The hypothesis of this research is that the consumption of n-3 PUFAs in the form of functionally enriched chicken meet has a beneficial effect on vascular reactivity measured in different vascular beds, and the lipid profile with a positive effect on the reduction of oxidative stress and inflammatory response in healthy sedentary individuals.

The main goal of this study is to investigate the influence of n-3 PUFAs functionally enriched chicken meet on vascular and endothelial function in a population of healthy young subjects and active athletes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impacts of Omega-3-PUFA Enriched Chicken-meat and Eggs in Healthy Humans

NCT04127409

Healthy Diet

COMPLETED NA

Omega-3 Fatty Acids Enriched Food and Microvascular Reactivity

NCT02720250

Omega-3 Polyunsaturated Fatty Acids

UNKNOWN NA

Fish Oil-derived N-3 Polyunsaturated Fatty Acids and Extracellular Vesicles

NCT03203512

Extracellular Vesicles; Generation and Function

COMPLETED NA

Omega (n)-3 PUFA Enriched Beef & Health Outcomes.

NCT03967678

CVD Cholesterol; Metabolic Disorder Inflammation

COMPLETED NA

Omega-3-Index Response to Eating Poultry Foods Naturally Enriched With Omega-3 Polyunsaturated Fatty Acids

NCT06259825

Healthy Nutrition Healthy Adults

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

n-3 Polyunsaturated Fatty Acids

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

n-3 PUFA

Intake of n-3 PUFAs enriched chicken meet for three weeks

Group Type EXPERIMENTAL

N-3 PUFAs Chicken Meet

Intervention Type DIETARY_SUPPLEMENT

Intake of n-3 PUFAs enriched chicken meet for three weeks.

Control

Intake of regular chicken meet for three weeks

Group Type EXPERIMENTAL

Regular Chicken Meet

Intervention Type DIETARY_SUPPLEMENT

Intake of regular chicken meet for three weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

N-3 PUFAs Chicken Meet

Intake of n-3 PUFAs enriched chicken meet for three weeks.

Intervention Type DIETARY_SUPPLEMENT

Regular Chicken Meet

Intake of regular chicken meet for three weeks.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* young healthy sedentary individuals - did not perform regular physical activities for at least 12 months before conducting the study
* young healthy active athletes - have a minimum of 5 training sessions per week (mainly endurance training) for at least 12 months prior to conducting the study

Exclusion Criteria

* smoking
* hypertension
* coronary disease
* diabetes
* hyperlipidemia
* kidney damage
* cerebrovascular and peripheral artery diseases
* and any other disease that could have an impact on vascular and endothelial function

Minimum Eligible Age

18 Years

Maximum Eligible Age

39 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes